Salvador Bruno
-
- Colorectal Cancer Treatments and Studies 2
- Dermatology top 10%
-
- Chronic Lymphocytic Leukemia Research 2
-
- Nausea and vomiting management 2
- Bladder and Urothelial Cancer Treatments 2
-
- Cancer, Hypoxia, and Metabolism 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
-
- Eosinophilic Disorders and Syndromes 2
-
- Renal cell carcinoma treatment 2
- Co-authors
- Raymond B. WeissJohn S. PentaJohn S. MacdonaldScott AntoniaLawrence BerkSophie DessureaultElihu J. LedesmaSteven E. Finkelstein
- Partner nations
- United StatesBelgiumItaly
In The Last Decade
Salvador Bruno
23 papers receiving 441 citations
Peers
Comparison fields: 5 of 71
- Oncology 229
- Dermatology 60
- Pathology and Forensic Medicine 102
- Genetics 52
- Pharmacology 70
Countries citing papers authored by Salvador Bruno
This map shows the geographic impact of Salvador Bruno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvador Bruno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvador Bruno more than expected).
Fields of papers citing papers by Salvador Bruno
This network shows the impact of papers produced by Salvador Bruno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvador Bruno. The network helps show where Salvador Bruno may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Salvador Bruno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 7 | |
| 2 | 2011 | 82 | |
| 3 | 2010 | 34 | |
| 4 | 2002 | 8 | |
| 5 | 1995 | 72 | |
| 6 | 1993 | 4 | |
| 7 | 1983 | 13 | |
| 8 | Dialogue en enfer | 1982 | 4 |
| 9 | Phase I study of high-dose methotrexate with thymidine and low-dose leucovorin. | 1982 | 3 |
| 10 | 1982 | 3 | |
| 11 | 1982 | 16 | |
| 12 | 1982 | 1 | |
| 13 | 1982 | 3 | |
| 14 | 1982 | 2 | |
| 15 | Treatment of cancer chemotherapy-induced nausea and vomiting | 1981 | 35 |
| 16 | Current status of chemotherapy in the treatment of advanced carcinoma of the thyroid gland. | 1981 | 16 |
| 17 | 1981 | 10 | |
| 18 | 1981 | 87 | |
| 19 | 2'-deoxycoformycin. A new anticancer agent. | 1981 | 6 |
| 20 | Daunorubicin treatment of adult solid tumors. | 1981 | 9 |
About Salvador Bruno
Salvador Bruno is a scholar working on Dermatology, Genetics and Oncology, having authored 23 papers that have together received 472 indexed citations. Recurring topics across this work include Nausea and vomiting management (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Eosinophilic Disorders and Syndromes (2 papers), Renal cell carcinoma treatment (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (229 citations), Dermatology (60 citations) and Pathology and Forensic Medicine (102 citations). Salvador Bruno has collaborated with scholars based in United States, Belgium and Italy. Frequent co-authors include Raymond B. Weiss, John S. Penta, John S. Macdonald, Scott Antonia, Lawrence Berk, Sophie Dessureault, Elihu J. Ledesma, Steven E. Finkelstein, R B Weiss and G L Neil. Their work appears in journals such as Annals of Internal Medicine, The Journal of Urology and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.